PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: CANCER, LEUKEMIA

该子项目是利用由NIH/NCRR资助的共享仪器补助金提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是资助机构，不一定是研究者的机构。描述（由申请人提供）：本提案要求一个Finnigan ProteomeX LTQ工作站，一个集成色谱电喷雾电离线性离子阱质谱仪，以使我们的基础和转化蛋白质组学中心/共享研究设施的分析能力达到最先进的水平，并增加我们的能力，以满足我们研究人员不断增加的工作量和工作强度。这一要求对于支持我们正在进行的研究项目，以及在蛋白质鉴定、翻译后修饰表征、基因发现和功能蛋白质组学方面刺激和实现新的合作研究计划至关重要。目前，西奈山医学中心（医院和医学院）没有ESI-LTQ线性离子阱质谱仪，这是提出这一要求的根本原因。ProteomeX LTQ工作站被要求取代我们老旧的Finnigan LCQ经典质谱仪，该质谱仪经常发生故障，严重影响了正在进行的研究项目。所要求的ProteomeX LTQ线性离子阱质谱仪将被安置在我们的基础和转化蛋白质组学中心。购买ProteomeX LTQ线性离子阱质谱仪对西奈山校区继续扩大和加强基础研究项目和人类疾病转化蛋白质组学研究至关重要。如本申请所述，来自10个不同部门的超过22名nih资助的研究人员和来自邻近研究所的2名nih资助的研究人员对该质谱仪有特定需求，这将是一个共享的研究资源。事实上，由于缺乏高灵敏度和高通量的蛋白质组学仪器，一些研究项目严重拖延或受损。因此，购买ProteomeX LTQ系统将对我们研究所的研究能力产生重大影响

This subproject is one of many research subprojects utilizing the resources provided by a Shared Instrumentation Grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the grant, which is not necessarily the institution for the investigator. DESCRIPTION (provided by applicant): This proposal requests a Finnigan ProteomeX LTQ workstation, an integrated chromatography electrospray ionization linear ion trap mass spectrometer to bring our Basic and Translational Proteomics Center / Shared Research Facility's analytical capability up to state-of-the-art and to increase our capacity to meet the ever increasing volume and intensity of work by our investigators. This request is essential to support our ongoing research programs and to stimulate and enable new collaborative research initiatives on protein identification, posttranslational modification characterization, gene discovery, and functional proteomics. Currently, there is no ESI-LTQ linear ion trap mass spectrometer at the Mount Sinai Medical Center (Hospital and School of Medicine), which provides a fundamental reason for this request. The ProteomeX LTQ workstation is requested in replace of our aged Finnigan LCQ classic mass spectrometer which breaks down so frequently that it seriously affects the on-going research projects. The requested ProteomeX LTQ linear ion trap mass spectrometer will be housed in our Basic and Translational Proteomics Center. The purchase of the ProteomeX LTQ linear ion trap mass spectrometer is fundamental to the continuing expansion and enhancement of the basic research programs and translational proteomics research for human disease on the Mount Sinai campus. As described in this application, over 22 NIH-funded investigators from 10 different departments and two NIH-funded investigators from neighboring institutes have specific needs for this mass spectrometer, which will be a shared research resource. Indeed, due to the lack of an highly sensitive and high throughput proteomics instrument on campus, some of these research projects are seriously delayed or compromised. Thus, the purchase of the ProteomeX LTQ system will have a major impact on the research capabilities at our instituti